Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).

The global Cyclospora Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cyclospora Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclospora Diagnostic Testing.

Report Scope

The Cyclospora Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cyclospora Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cyclospora Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cyclospora Diagnostic Testing Market Report

Report Metric	Details
Report Name	Cyclospora Diagnostic Testing Market
CAGR	5%
Segment by Type	Acid-fast Staining Safranin Staining
Segment by Application	Commercial or Private Laboratories Hospitals Public Health Labs Physician Offices
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Beckman Coulter, Inc, bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc, Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company), DiaSorin S.p.A., Roche Diagnostics (a division of Hoffmann-La Roche), Siemens Healthcare, QIAGEN N.V., Wako Chemicals USA, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyclospora Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cyclospora Diagnostic Testing Market report?

Ans: The main players in the Cyclospora Diagnostic Testing Market are Thermo Fisher Scientific, Beckman Coulter, Inc, bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc, Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company), DiaSorin S.p.A., Roche Diagnostics (a division of Hoffmann-La Roche), Siemens Healthcare, QIAGEN N.V., Wako Chemicals USA, Inc.

What are the Application segmentation covered in the Cyclospora Diagnostic Testing Market report?

Ans: The Applications covered in the Cyclospora Diagnostic Testing Market report are Commercial or Private Laboratories, Hospitals, Public Health Labs, Physician Offices

What are the Type segmentation covered in the Cyclospora Diagnostic Testing Market report?

Ans: The Types covered in the Cyclospora Diagnostic Testing Market report are Acid-fast Staining, Safranin Staining

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Acid-fast Staining

1.2.3 Safranin Staining

1.3 Market by Application

1.3.1 Global Cyclospora Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Commercial or Private Laboratories

1.3.3 Hospitals

1.3.4 Public Health Labs

1.3.5 Physician Offices

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cyclospora Diagnostic Testing Market Perspective (2019-2030)

2.2 Cyclospora Diagnostic Testing Growth Trends by Region

2.2.1 Global Cyclospora Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cyclospora Diagnostic Testing Historic Market Size by Region (2019-2024)

2.2.3 Cyclospora Diagnostic Testing Forecasted Market Size by Region (2025-2030)

2.3 Cyclospora Diagnostic Testing Market Dynamics

2.3.1 Cyclospora Diagnostic Testing Industry Trends

2.3.2 Cyclospora Diagnostic Testing Market Drivers

2.3.3 Cyclospora Diagnostic Testing Market Challenges

2.3.4 Cyclospora Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cyclospora Diagnostic Testing Players by Revenue

3.1.1 Global Top Cyclospora Diagnostic Testing Players by Revenue (2019-2024)

3.1.2 Global Cyclospora Diagnostic Testing Revenue Market Share by Players (2019-2024)

3.2 Global Cyclospora Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cyclospora Diagnostic Testing Revenue

3.4 Global Cyclospora Diagnostic Testing Market Concentration Ratio

3.4.1 Global Cyclospora Diagnostic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cyclospora Diagnostic Testing Revenue in 2023

3.5 Cyclospora Diagnostic Testing Key Players Head office and Area Served

3.6 Key Players Cyclospora Diagnostic Testing Product Solution and Service

3.7 Date of Enter into Cyclospora Diagnostic Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cyclospora Diagnostic Testing Breakdown Data by Type

4.1 Global Cyclospora Diagnostic Testing Historic Market Size by Type (2019-2024)

4.2 Global Cyclospora Diagnostic Testing Forecasted Market Size by Type (2025-2030)

5 Cyclospora Diagnostic Testing Breakdown Data by Application

5.1 Global Cyclospora Diagnostic Testing Historic Market Size by Application (2019-2024)

5.2 Global Cyclospora Diagnostic Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cyclospora Diagnostic Testing Market Size (2019-2030)

6.2 North America Cyclospora Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

6.4 North America Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cyclospora Diagnostic Testing Market Size (2019-2030)

7.2 Europe Cyclospora Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

7.4 Europe Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cyclospora Diagnostic Testing Market Size (2019-2030)

8.2 Asia-Pacific Cyclospora Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cyclospora Diagnostic Testing Market Size (2019-2030)

9.2 Latin America Cyclospora Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

9.4 Latin America Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cyclospora Diagnostic Testing Market Size (2019-2030)

10.2 Middle East & Africa Cyclospora Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Cyclospora Diagnostic Testing Introduction

11.1.4 Thermo Fisher Scientific Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Beckman Coulter, Inc

11.2.1 Beckman Coulter, Inc Company Detail

11.2.2 Beckman Coulter, Inc Business Overview

11.2.3 Beckman Coulter, Inc Cyclospora Diagnostic Testing Introduction

11.2.4 Beckman Coulter, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.2.5 Beckman Coulter, Inc Recent Development

11.3 bioMerieux, Inc.

11.3.1 bioMerieux, Inc. Company Detail

11.3.2 bioMerieux, Inc. Business Overview

11.3.3 bioMerieux, Inc. Cyclospora Diagnostic Testing Introduction

11.3.4 bioMerieux, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.3.5 bioMerieux, Inc. Recent Development

11.4 CEPHEID

11.4.1 CEPHEID Company Detail

11.4.2 CEPHEID Business Overview

11.4.3 CEPHEID Cyclospora Diagnostic Testing Introduction

11.4.4 CEPHEID Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.4.5 CEPHEID Recent Development

11.5 Diamedix Corporation

11.5.1 Diamedix Corporation Company Detail

11.5.2 Diamedix Corporation Business Overview

11.5.3 Diamedix Corporation Cyclospora Diagnostic Testing Introduction

11.5.4 Diamedix Corporation Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.5.5 Diamedix Corporation Recent Development

11.6 Hologic, Inc

11.6.1 Hologic, Inc Company Detail

11.6.2 Hologic, Inc Business Overview

11.6.3 Hologic, Inc Cyclospora Diagnostic Testing Introduction

11.6.4 Hologic, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.6.5 Hologic, Inc Recent Development

11.7 Nanogen, Inc.

11.7.1 Nanogen, Inc. Company Detail

11.7.2 Nanogen, Inc. Business Overview

11.7.3 Nanogen, Inc. Cyclospora Diagnostic Testing Introduction

11.7.4 Nanogen, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.7.5 Nanogen, Inc. Recent Development

11.8 Ortho Clinical Diagnostics (a Johnson & Johnson company)

11.8.1 Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Detail

11.8.2 Ortho Clinical Diagnostics (a Johnson & Johnson company) Business Overview

11.8.3 Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Introduction

11.8.4 Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.8.5 Ortho Clinical Diagnostics (a Johnson & Johnson company) Recent Development

11.9 DiaSorin S.p.A.

11.9.1 DiaSorin S.p.A. Company Detail

11.9.2 DiaSorin S.p.A. Business Overview

11.9.3 DiaSorin S.p.A. Cyclospora Diagnostic Testing Introduction

11.9.4 DiaSorin S.p.A. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.9.5 DiaSorin S.p.A. Recent Development

11.10 Roche Diagnostics (a division of Hoffmann-La Roche)

11.10.1 Roche Diagnostics (a division of Hoffmann-La Roche) Company Detail

11.10.2 Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview

11.10.3 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Introduction

11.10.4 Roche Diagnostics (a division of Hoffmann-La Roche) Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.10.5 Roche Diagnostics (a division of Hoffmann-La Roche) Recent Development

11.11 Siemens Healthcare

11.11.1 Siemens Healthcare Company Detail

11.11.2 Siemens Healthcare Business Overview

11.11.3 Siemens Healthcare Cyclospora Diagnostic Testing Introduction

11.11.4 Siemens Healthcare Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.11.5 Siemens Healthcare Recent Development

11.12 QIAGEN N.V.

11.12.1 QIAGEN N.V. Company Detail

11.12.2 QIAGEN N.V. Business Overview

11.12.3 QIAGEN N.V. Cyclospora Diagnostic Testing Introduction

11.12.4 QIAGEN N.V. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.12.5 QIAGEN N.V. Recent Development

11.13 Wako Chemicals USA, Inc.

11.13.1 Wako Chemicals USA, Inc. Company Detail

11.13.2 Wako Chemicals USA, Inc. Business Overview

11.13.3 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Introduction

11.13.4 Wako Chemicals USA, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024)

11.13.5 Wako Chemicals USA, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

Ortho Clinical Diagnostics (a Johnson & Johnson company)

DiaSorin

Siemens Healthcare

QIAGEN N V

Wako Chemicals USA, Inc.

List of Tables

Table 1. Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Acid-fast Staining

Table 3. Key Players of Safranin Staining

Table 4. Global Cyclospora Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Cyclospora Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cyclospora Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cyclospora Diagnostic Testing Market Share by Region (2019-2024)

Table 8. Global Cyclospora Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cyclospora Diagnostic Testing Market Share by Region (2025-2030)

Table 10. Cyclospora Diagnostic Testing Market Trends

Table 11. Cyclospora Diagnostic Testing Market Drivers

Table 12. Cyclospora Diagnostic Testing Market Challenges

Table 13. Cyclospora Diagnostic Testing Market Restraints

Table 14. Global Cyclospora Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cyclospora Diagnostic Testing Market Share by Players (2019-2024)

Table 16. Global Top Cyclospora Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclospora Diagnostic Testing as of 2023)

Table 17. Ranking of Global Top Cyclospora Diagnostic Testing Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Cyclospora Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Cyclospora Diagnostic Testing Product Solution and Service

Table 21. Date of Enter into Cyclospora Diagnostic Testing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cyclospora Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2019-2024)

Table 25. Global Cyclospora Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2025-2030)

Table 27. Global Cyclospora Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cyclospora Diagnostic Testing Revenue Market Share by Application (2019-2024)

Table 29. Global Cyclospora Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cyclospora Diagnostic Testing Revenue Market Share by Application (2025-2030)

Table 31. North America Cyclospora Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Cyclospora Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Cyclospora Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Cyclospora Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Cyclospora Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Thermo Fisher Scientific Company Detail

Table 47. Thermo Fisher Scientific Business Overview

Table 48. Thermo Fisher Scientific Cyclospora Diagnostic Testing Product

Table 49. Thermo Fisher Scientific Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 50. Thermo Fisher Scientific Recent Development

Table 51. Beckman Coulter, Inc Company Detail

Table 52. Beckman Coulter, Inc Business Overview

Table 53. Beckman Coulter, Inc Cyclospora Diagnostic Testing Product

Table 54. Beckman Coulter, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 55. Beckman Coulter, Inc Recent Development

Table 56. bioMerieux, Inc. Company Detail

Table 57. bioMerieux, Inc. Business Overview

Table 58. bioMerieux, Inc. Cyclospora Diagnostic Testing Product

Table 59. bioMerieux, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 60. bioMerieux, Inc. Recent Development

Table 61. CEPHEID Company Detail

Table 62. CEPHEID Business Overview

Table 63. CEPHEID Cyclospora Diagnostic Testing Product

Table 64. CEPHEID Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 65. CEPHEID Recent Development

Table 66. Diamedix Corporation Company Detail

Table 67. Diamedix Corporation Business Overview

Table 68. Diamedix Corporation Cyclospora Diagnostic Testing Product

Table 69. Diamedix Corporation Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 70. Diamedix Corporation Recent Development

Table 71. Hologic, Inc Company Detail

Table 72. Hologic, Inc Business Overview

Table 73. Hologic, Inc Cyclospora Diagnostic Testing Product

Table 74. Hologic, Inc Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 75. Hologic, Inc Recent Development

Table 76. Nanogen, Inc. Company Detail

Table 77. Nanogen, Inc. Business Overview

Table 78. Nanogen, Inc. Cyclospora Diagnostic Testing Product

Table 79. Nanogen, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 80. Nanogen, Inc. Recent Development

Table 81. Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Detail

Table 82. Ortho Clinical Diagnostics (a Johnson & Johnson company) Business Overview

Table 83. Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Product

Table 84. Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 85. Ortho Clinical Diagnostics (a Johnson & Johnson company) Recent Development

Table 86. DiaSorin S.p.A. Company Detail

Table 87. DiaSorin S.p.A. Business Overview

Table 88. DiaSorin S.p.A. Cyclospora Diagnostic Testing Product

Table 89. DiaSorin S.p.A. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 90. DiaSorin S.p.A. Recent Development

Table 91. Roche Diagnostics (a division of Hoffmann-La Roche) Company Detail

Table 92. Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview

Table 93. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product

Table 94. Roche Diagnostics (a division of Hoffmann-La Roche) Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 95. Roche Diagnostics (a division of Hoffmann-La Roche) Recent Development

Table 96. Siemens Healthcare Company Detail

Table 97. Siemens Healthcare Business Overview

Table 98. Siemens Healthcare Cyclospora Diagnostic Testing Product

Table 99. Siemens Healthcare Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 100. Siemens Healthcare Recent Development

Table 101. QIAGEN N.V. Company Detail

Table 102. QIAGEN N.V. Business Overview

Table 103. QIAGEN N.V. Cyclospora Diagnostic Testing Product

Table 104. QIAGEN N.V. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 105. QIAGEN N.V. Recent Development

Table 106. Wako Chemicals USA, Inc. Company Detail

Table 107. Wako Chemicals USA, Inc. Business Overview

Table 108. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product

Table 109. Wako Chemicals USA, Inc. Revenue in Cyclospora Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 110. Wako Chemicals USA, Inc. Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cyclospora Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cyclospora Diagnostic Testing Market Share by Type: 2023 VS 2030

Figure 3. Acid-fast Staining Features

Figure 4. Safranin Staining Features

Figure 5. Global Cyclospora Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Cyclospora Diagnostic Testing Market Share by Application: 2023 VS 2030

Figure 7. Commercial or Private Laboratories Case Studies

Figure 8. Hospitals Case Studies

Figure 9. Public Health Labs Case Studies

Figure 10. Physician Offices Case Studies

Figure 11. Cyclospora Diagnostic Testing Report Years Considered

Figure 12. Global Cyclospora Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cyclospora Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cyclospora Diagnostic Testing Market Share by Region: 2023 VS 2030

Figure 15. Global Cyclospora Diagnostic Testing Market Share by Players in 2023

Figure 16. Global Top Cyclospora Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclospora Diagnostic Testing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cyclospora Diagnostic Testing Revenue in 2023

Figure 18. North America Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 20. United States Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 24. Germany Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cyclospora Diagnostic Testing Market Share by Region (2019-2030)

Figure 32. China Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 40. Mexico Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cyclospora Diagnostic Testing Market Share by Country (2019-2030)

Figure 44. Turkey Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Cyclospora Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 47. Beckman Coulter, Inc Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 48. bioMerieux, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 49. CEPHEID Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 50. Diamedix Corporation Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 51. Hologic, Inc Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 52. Nanogen, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 53. Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 54. DiaSorin S.p.A. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 55. Roche Diagnostics (a division of Hoffmann-La Roche) Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 56. Siemens Healthcare Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 57. QIAGEN N.V. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 58. Wako Chemicals USA, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions